Ferneau Philip 4
4 · Compass Therapeutics, Inc. · Filed Feb 23, 2022
Insider Transaction Report
Form 4
Ferneau Philip
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-02-18+30,000→ 30,000 totalExercise: $2.40Exp: 2032-02-17→ Common Stock (30,000 underlying)
Footnotes (2)
- [F1]This option vests in substantially equal monthly installments over four years.
- [F2]The Reporting Person is a managing partner of Borealis Ventures. Pursuant to an agreement with Borealis Ventures, the Reporting Person is obligated to transfer any securities issued under any stock options or other awards, or the economic benefit thereof, to Borealis Granite Fund, L.P. and Vox Health Fund, L.P.